The coronavirus pandemic has inspired many healthcare companies to work towards tackling the problem and thrown up interesting investment opportunities.
One of the latest ones to enter the fray is the relatively small healthcare company SINTX Technologies Inc (NASDAQ: SINT). The company, which is involved in the research and manufacturing of medical implants, believes that its research facilities can help in the fight against COVID 19 and that resulted in a rally in the stock. The SINTX stock soared by as high as 58.50% on Tuesday and has emerged as a possible coronavirus play.
The company makes the implants from silicon nitride and back in June last year, SINTX had announced that silicon nitride could help in inactivating viruses. In a new development, the company announced on Tuesday that a study into silicon nitride particles by the University of Rochester showed that it can actually inactivate COVID-19. It is a major boost for SINTX and the rally in the stock is understandable. Investors could consider keeping an eye on fresh developments.